活血利水中药联阿托伐他汀钙对颈动脉粥样硬化血管内皮功能的干预研究.pdfVIP

下载本文档

10
0
约3.85万字
约 39页
2016-03-25 发布于贵州
举报
版权申诉

活血利水中药联阿托伐他汀钙对颈动脉粥样硬化血管内皮功能的干预研究.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

活血利水中药联阿托伐他汀钙对颈动脉粥样硬化血管内皮功能的干预研究

目录主要缩略词 ·················································1 中文摘要 ···················································2 英文摘要 ···················································3 引言 ····················································4 正文 ····················································5 1 实验设计与研究方法 ·····································5 1.1 实验目的·················································5 1.2 诊断标准 ·················································5 1.2.1 血瘀证诊断参考标准 ·····································5 1.2.2 纳入病例标准 ·······································5 1.2.3 排除病例标准 ·······································5 1.2.4 病例剔除标准 ·······································6 1.3 研究对象 ···············································6 1.3.1 病例来源及分组 ·····································6 1.3.2 一般资料分析 ·······································6 1.4 治疗及观察方法 ·······································7 1.4.1 药物 ·················································7 1.4.2 治疗方法 ············································7 1.4.3 疗程 ·················································8 1.4.4 观察项目及方法 ·····································8 1.4.4.1 疗效观察 ··········································8 1.4.4.2 安全性观察项目及方法 ···························8 1.5 统计方法 ···············································9 2 研究结果 ·················································9 2.1 两组血瘀证证侯评分 ···································9 2.2 血管内皮舒张功能的变化 ·····························9 2.3 内皮素(ET)及血栓素 B2(TXB2) 的变化 ················10 2.4 并发症 ················································10 2.5 安全性观测及不良反应 ·······························10 3 讨论 ·····················································10 3.1 现代医学对颈动脉粥样硬化的认识 ···················10 3.1.1 CAS 发病的危险因素 ································11 3.1.2 现代医学对 CAS 发病机制的认识 ····················12 3.1.3 现代医学对 CAS 的治疗 ······························14 3.2 中医学对颈动脉粥样硬化的认识 ······················16 3.3 活血利水中药复方药物